These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23416144)

  • 1. Cysteamine: an old drug with new potential.
    Besouw M; Masereeuw R; van den Heuvel L; Levtchenko E
    Drug Discov Today; 2013 Aug; 18(15-16):785-92. PubMed ID: 23416144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases.
    Gibrat C; Cicchetti F
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):380-9. PubMed ID: 21111020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous delivery of cysteamine for the treatment of cystinosis: association with hepatotoxicity.
    Bendel-Stenzel MR; Steinke J; Dohil R; Kim Y
    Pediatr Nephrol; 2008 Feb; 23(2):311-5. PubMed ID: 17668247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteamine: new preparation. Chronic treatment of cystinosis.
    Prescrire Int; 1999 Jun; 8(41):67-70. PubMed ID: 10558441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYTE-I-HD: phase I dose finding and tolerability study of cysteamine (Cystagon) in Huntington's disease.
    Dubinsky R; Gray C
    Mov Disord; 2006 Apr; 21(4):530-3. PubMed ID: 16258942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of enteric-coated cysteamine bitartrate in healthy adults: a pilot study.
    Gangoiti JA; Fidler M; Cabrera BL; Schneider JA; Barshop BA; Dohil R
    Br J Clin Pharmacol; 2010 Sep; 70(3):376-82. PubMed ID: 20716238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fertility status in male cystinosis patients treated with cysteamine.
    Besouw MT; Kremer JA; Janssen MC; Levtchenko EN
    Fertil Steril; 2010 Apr; 93(6):1880-3. PubMed ID: 19217094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the effectiveness of cysteamine and phosphocysteamine in elevating plasma cysteamine concentration and decreasing leukocyte free cystine in nephropathic cystinosis.
    Smolin LA; Clark KF; Thoene JG; Gahl WA; Schneider JA
    Pediatr Res; 1988 Jun; 23(6):616-20. PubMed ID: 3393396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of cysteamine at fractionated irradiation. 3. Histopathologic diagnoses at death.
    Nelson A; Järplid B; Nilsson A; Rönnbäck C; Eriksson KH
    Acta Radiol Suppl; 1971; 310():181-99. PubMed ID: 5293600
    [No Abstract]   [Full Text] [Related]  

  • 10. Quiz page. Fanconi syndrome caused by cystinosis, intermediate type.
    Ram R; Swarnalatha G; Reddy PN; Prasad N; Dakshinamurty KV
    Am J Kidney Dis; 2009 Dec; 54(6):xxxviii-xxxix. PubMed ID: 19932873
    [No Abstract]   [Full Text] [Related]  

  • 11. [Kinetic study of radiolesions of the testis in rats. Abs5nce of the protective effect of cysteamine].
    Maldague P; Maisin H
    Pathol Eur; 1966; 1(1):67-84. PubMed ID: 5989465
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous cysteamine therapy for nephropathic cystinosis.
    Gahl WA; Ingelfinger J; Mohan P; Bernardini I; Hyman PE; Tangerman A
    Pediatr Res; 1995 Oct; 38(4):579-84. PubMed ID: 8559613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cysteamine in the treatment of cystinosis in children. In vitro and in vivo studies].
    Louis JJ; Guibaud P; Dumoulin R; Parchoux B; Zabot MT; Bureau J; Baltassat P; Frederich A; Larbre F
    Pediatrie; 1984 Dec; 39(8):619-33. PubMed ID: 6535971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intra-leukocyte cystine in cystinosis treated with cysteamine].
    Ged C; Jean G; Tete MJ; Broyer M; Kamoun P
    Ann Biol Clin (Paris); 1991; 49(9):482-6. PubMed ID: 1789502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of cysteamine on the teratogenic action of X-rays in golden hamster. Preliminary report.
    Kulig A; Kowalczyk K; Plonkowa I
    Pol Med J; 1969; 8(4):902-8. PubMed ID: 5404483
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term treatment of cystinosis in children with twice-daily cysteamine.
    Dohil R; Gangoiti JA; Cabrera BL; Fidler M; Schneider JA; Barshop BA
    J Pediatr; 2010 May; 156(5):823-7. PubMed ID: 20138296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cysteamine bitartrate on adiponectin multimerization in non-alcoholic fatty liver disease and healthy subjects.
    Dohil R; Meyer L; Schmeltzer S; Cabrera BL; Lavine JE; Phillips SA
    J Pediatr; 2012 Oct; 161(4):639-45.e1. PubMed ID: 22633783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cysteamine therapy for children with nephropathic cystinosis.
    Gahl WA; Reed GF; Thoene JG; Schulman JD; Rizzo WB; Jonas AJ; Denman DW; Schlesselman JJ; Corden BJ; Schneider JA
    N Engl J Med; 1987 Apr; 316(16):971-7. PubMed ID: 3550461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the mechanism of radioprotection by cysteamine. II. The significance of cyclic 3',5'-AMP for the cysteamine-induced radioprotective effects in white mice.
    Mitznegg P
    Int J Radiat Biol Relat Stud Phys Chem Med; 1973 Oct; 24(4):339-44. PubMed ID: 4355921
    [No Abstract]   [Full Text] [Related]  

  • 20. Cystinosis. Intracellular cystine depletion by aminothiols in vitro and in vivo.
    Thoene JG; Oshima RG; Crawhall JC; Olson DL; Schneider JA
    J Clin Invest; 1976 Jul; 58(1):180-9. PubMed ID: 932205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.